XPON vs GNSS vs CBAT vs NRGV vs FLUX

For growth investors, Energy Vault Holdings, Inc.

(NRGV) is the stronger pick with 340. 9% revenue growth year-over-year, versus -13. 6% for CBAK Energy Technology, Inc. (CBAT). CBAK Energy Technology, Inc. (CBAT) offers the better valuation at 6. 0x trailing P/E, making it the more compelling value choice. Analysts rate Energy Vault Holdings, Inc. (NRGV) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Energy Vault Holdings, Inc.

(NRGV) delivered a total return of -57. 7%, compared to -99. 9% for Expion360 Inc. (XPON). Over 10 years, the gap is even starker: GNSS returned +14. 9% versus XPON's -99. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Genasys Inc.

(GNSS) is the lower-risk stock at 0. 87β versus Expion360 Inc. 's 3. 34β — meaning XPON is approximately 285% more volatile than GNSS relative to the S&P 500. On balance sheet safety, CBAK Energy Technology, Inc. (CBAT) carries a lower debt/equity ratio of 25% versus 10% for Genasys Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Energy Vault Holdings, Inc.

(NRGV) is pulling ahead at 340. 9% versus -13. 6% for CBAK Energy Technology, Inc. (CBAT). On earnings-per-share growth, the picture is similar: CBAK Energy Technology, Inc. grew EPS 574. 5% year-over-year, compared to -1847. 2% for Expion360 Inc.. Over a 3-year CAGR, CBAT leads at 49. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

CBAK Energy Technology, Inc.

(CBAT) is the more profitable company, earning 6. 7% net margin versus -239. 6% for Expion360 Inc. — meaning it keeps 6. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CBAT leads at 5. 0% versus -120. 1% for XPON. At the gross margin level — before operating expenses — GNSS leads at 41. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Genasys Inc.

(GNSS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 87)). Expion360 Inc. (XPON) carries a higher beta of 3. 34 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (GNSS: +14. 9%, XPON: -99. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (XPON (Industrials) and GNSS (Technology) and CBAT (Industrials) and NRGV (Utilities) and FLUX (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: XPON is a small-cap quality compounder stock; GNSS is a small-cap high-growth stock; CBAT is a small-cap deep-value stock; NRGV is a small-cap high-growth stock; FLUX is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.